159 related articles for article (PubMed ID: 32775453)
1. miR-520h Stimulates Drug Resistance to Paclitaxel by Targeting the OTUD3-PTEN Axis in Breast Cancer.
Geng W; Song H; Zhao Q; Dong K; Pu Q; Gao H; Lv Y
Biomed Res Int; 2020; 2020():9512793. PubMed ID: 32775453
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling pathway.
Shen H; Li L; Yang S; Wang D; Zhong S; Zhao J; Tang J
Gene; 2016 Nov; 593(1):84-90. PubMed ID: 27523474
[TBL] [Abstract][Full Text] [Related]
3. Bone Marrow Stromal Cell-Secreted Extracellular Vesicles Containing miR-34c-5p Alleviate Lung Injury and Inflammation in Bronchopulmonary Dysplasia Through Promotion of PTEN Degradation by Targeting OTUD3.
He X; Kuang J; Wang Y; Lan G; Shi X
Immunol Invest; 2023 Nov; 52(6):681-702. PubMed ID: 37310728
[TBL] [Abstract][Full Text] [Related]
4. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27
Wang DD; Yang SJ; Chen X; Shen HY; Luo LJ; Zhang XH; Zhong SL; Zhao JH; Tang JH
Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665
[TBL] [Abstract][Full Text] [Related]
5. miR-520h is crucial for DAPK2 regulation and breast cancer progression.
Su CM; Wang MY; Hong CC; Chen HA; Su YH; Wu CH; Huang MT; Chang YW; Jiang SS; Sung SY; Chang JY; Chen LT; Chen PS; Su JL
Oncogene; 2016 Mar; 35(9):1134-42. PubMed ID: 25982274
[TBL] [Abstract][Full Text] [Related]
6. MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway.
Shen H; Wang D; Li L; Yang S; Chen X; Zhou S; Zhong S; Zhao J; Tang J
Gene; 2017 Jan; 596():110-118. PubMed ID: 27746366
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of exosomal miR-9 and miR-155 targeting PTEN and DUSP14 in highly metastatic breast cancer and their effect on low metastatic cells.
Kia V; Paryan M; Mortazavi Y; Biglari A; Mohammadi-Yeganeh S
J Cell Biochem; 2019 Apr; 120(4):5666-5676. PubMed ID: 30335891
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-21 modulates chemosensitivity of breast cancer cells to doxorubicin by targeting PTEN.
Wang ZX; Lu BB; Wang H; Cheng ZX; Yin YM
Arch Med Res; 2011 May; 42(4):281-90. PubMed ID: 21820606
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-132 and microRNA-212 mediate doxorubicin resistance by down-regulating the PTEN-AKT/NF-κB signaling pathway in breast cancer.
Xie M; Fu Z; Cao J; Liu Y; Wu J; Li Q; Chen Y
Biomed Pharmacother; 2018 Jun; 102():286-294. PubMed ID: 29567542
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of miR-129-5p increases the sensitivity to Taxol through inhibiting HMGB1-mediated cell autophagy in breast cancer MCF-7 cells.
Shi Y; Gong W; Lu L; Wang Y; Ren J
Braz J Med Biol Res; 2019; 52(11):e8657. PubMed ID: 31664305
[TBL] [Abstract][Full Text] [Related]
11. MiR-202-5p/
Liu T; Guo J; Zhang X
Cancer Biol Ther; 2019; 20(7):989-998. PubMed ID: 30983514
[TBL] [Abstract][Full Text] [Related]
12. MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer.
Li N; Miao Y; Shan Y; Liu B; Li Y; Zhao L; Jia L
Cell Death Dis; 2017 May; 8(5):e2796. PubMed ID: 28518139
[TBL] [Abstract][Full Text] [Related]
13. Apoptotic effects of valproic acid on miR-34a, miR-520h and HDAC1 gene in breast cancer.
Injinari N; Amini-Farsani Z; Yadollahi-Farsani M; Teimori H
Life Sci; 2021 Mar; 269():119027. PubMed ID: 33453248
[TBL] [Abstract][Full Text] [Related]
14. Involvement of miR-451 in resistance to paclitaxel by regulating YWHAZ in breast cancer.
Wang W; Zhang L; Wang Y; Ding Y; Chen T; Wang Y; Wang H; Li Y; Duan K; Chen S; Yang Q; Chen C
Cell Death Dis; 2017 Oct; 8(10):e3071. PubMed ID: 28981108
[TBL] [Abstract][Full Text] [Related]
15. miR-93 and PTEN: Key regulators of doxorubicin-resistance and EMT in breast cancer.
Chu S; Liu G; Xia P; Chen G; Shi F; Yi T; Zhou H
Oncol Rep; 2017 Oct; 38(4):2401-2407. PubMed ID: 28765915
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-222 promotes drug resistance to doxorubicin in breast cancer via regulation of miR-222/bim pathway.
Dai H; Xu LY; Qian Q; Zhu QW; Chen WX
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31273056
[TBL] [Abstract][Full Text] [Related]
17. miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation.
Bahena-Ocampo I; Espinosa M; Ceballos-Cancino G; Lizarraga F; Campos-Arroyo D; Schwarz A; Maldonado V; Melendez-Zajgla J; Garcia‐Lopez P
EMBO Rep; 2016 May; 17(5):648-58. PubMed ID: 27113763
[TBL] [Abstract][Full Text] [Related]
18. Deubiquitylase OTUD3 regulates PTEN stability and suppresses tumorigenesis.
Yuan L; Lv Y; Li H; Gao H; Song S; Zhang Y; Xing G; Kong X; Wang L; Li Y; Zhou T; Gao D; Xiao ZX; Yin Y; Wei W; He F; Zhang L
Nat Cell Biol; 2015 Sep; 17(9):1169-81. PubMed ID: 26280536
[TBL] [Abstract][Full Text] [Related]
19. miR-21 inhibitor suppresses cell proliferation and colony formation through regulating the PTEN/AKT pathway and improves paclitaxel sensitivity in cervical cancer cells.
Du G; Cao D; Meng L
Mol Med Rep; 2017 May; 15(5):2713-2719. PubMed ID: 28447761
[TBL] [Abstract][Full Text] [Related]
20. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
Hu Y; Xu K; Yagüe E
Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
